Design, Synthesis, and Biological Activity of Hydroxamic Tertiary Amines as Histone Deacetylase Inhibitors

被引：8
作者：
Terracciano, Stefania [1 ]
Chini, Maria Giovanna [1 ]
Riccio, Raffaele [1 ]
Bruno, Ines [1 ]
Bifulco, Giuseppe [1 ]
机构：
[1] Univ Salerno, Dipartimento Sci Farmaceut & Biomed, I-84084 Fisciano, SA, Italy
来源：
CHEMMEDCHEM | 2012年 / 7卷 / 04期
关键词：
docking; fluorimetric assays; inhibitors; histone deacetylase; hydroxamic tertiary amines; TRANS-RETINOIC ACID; REDUCTIVE ALKYLATION; EPIGENETIC THERAPY; MOLECULAR DOCKING; HDAC INHIBITORS; CLINICAL-TRIAL; VALPROIC ACID; PHASE-II; CANCER; DEPSIPEPTIDE;
D O I：
10.1002/cmdc.201100531
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Herein we describe the design, synthesis, and biological evaluation of new hydroxamic tertiary amines as histone deacetylase (HDAC) inhibitors. These compounds have allowed us to clarify the influence of cap group dimension and hydrophobicity on HDAC inhibitory activity. This report also reveals the recognition pattern between the linear compounds and the histone deacetylase-like protein (HDLP) model receptor, and discusses the synthesis and in vitro evaluation of HDAC inhibitory activity in HeLa cell nuclear extracts. We obtained good qualitative agreement between experimental results and theoretical predictions, confirming that appropriately substituted hydroxamic tertiary amines are potential active HDAC inhibitors.
引用
收藏
页码：694 / 702
页数：9
相关论文
共 60 条
  • [21] A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia
    Gimsing, Peter
    Hansen, Mads
    Knudsen, Lene M.
    Knoblauch, P.
    Christensen, Ib Jarle
    Ooi, Chean Eng
    Buhl-Jensen, Peter
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (03) : 170 - 176
  • [22] Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias
    Gojo, Ivana
    Jiemjit, Anchalee
    Trepel, Jane B.
    Sparreboom, Alex
    Figg, William D.
    Rollins, Sandra
    Tidwell, Michael L.
    Greer, Jacqueline
    Chung, Eun Joo
    Lee, Min-Jung
    Gore, Steven D.
    Sausville, Edward A.
    Zwiebel, James
    Karp, Judith E.
    [J]. BLOOD, 2007, 109 (07) : 2781 - 2790
  • [23] A phase I and pharmacokinetic study of the oral histone deacetylase inhibitor, MS-275, in patients with refractory solid tumors and lymphomas
    Gore, Lia
    Rothenberg, Mace L.
    O'Bryant, Cindy L.
    Schultz, Mary Kay
    Sandler, Alan B.
    Coffin, Denise
    McCoy, Candice
    Schott, Astrid
    Scholz, Catherine
    Eckhardt, S. Gail
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (14) : 4517 - 4525
  • [24] Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia
    Grignani, F
    De Matteis, S
    Nervi, C
    Tomassoni, L
    Gelmetti, V
    Cioce, M
    Fanelli, M
    Ruthardt, M
    Ferrara, FF
    Zamir, I
    Seiser, C
    Grignani, F
    Lazar, MA
    Minucci, S
    Pelicci, PG
    [J]. NATURE, 1998, 391 (6669) : 815 - 818
  • [25] Synthesis, Biological Evaluation, and Molecular Docking of Ugi Products Containing a Zinc-Chelating Moiety as Novel Inhibitors of Histone Deacetylases
    Grolla, Ambra A.
    Podesta, Valeria
    Chini, Maria Giovanna
    Di Micco, Simone
    Vallario, Antonella
    Genazzani, Armando A.
    Canonico, Pier Luigi
    Bifulco, Giuseppe
    Tron, Gian Cesare
    Sorba, Giovanni
    Pirali, Tracey
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (09) : 2776 - 2785
  • [26] Multicenter phase II trial of the historic deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma
    Hauschild, Axel
    Trefzer, Uwe
    Garbe, Claus
    Kaehler, Katharina C.
    Ugurel, Selma
    Kiecker, Felix
    Eigentler, Thomas
    Krissel, Heiko
    Schott, Astrid
    Schadendorf, Dirk
    [J]. MELANOMA RESEARCH, 2008, 18 (04) : 274 - 278
  • [27] Histone deacetylase inhibitors and cancer: from cell biology to the clinic
    Hess-Stumpp, H
    [J]. EUROPEAN JOURNAL OF CELL BIOLOGY, 2005, 84 (2-3) : 109 - 121
  • [28] Structure-based calculation of drug efficiency indices
    Hetenyi, Csaba
    Maran, Uko
    Garcia-Sosa, Alfonso T.
    Karelson, Mati
    [J]. BIOINFORMATICS, 2007, 23 (20) : 2678 - 2685
  • [29] HDAC6 is a microtubule-associated deacetylase
    Hubbert, C
    Guardiola, A
    Shao, R
    Kawaguchi, Y
    Ito, A
    Nixon, A
    Yoshida, M
    Wang, XF
    Yao, TP
    [J]. NATURE, 2002, 417 (6887) : 455 - 458
  • [30] Solid phase reductive alkylation of secondary amines.
    Khan, NM
    Arumugam, V
    Balasubramanian, S
    [J]. TETRAHEDRON LETTERS, 1996, 37 (27) : 4819 - 4822
123456